0001193125-25-256328
SEC filingNo Notes data extracted: input lacked financial figures.
No data available - the Notes section content was not provided in the input.
No data available.
No data available.
No data available.
For the nine months ended September 30, 2025, OPKO Health reported an operating cash outflow of $22.5 million, a significant improvement from the $37.1 million outflow in the same period of 2024. This 39.4% year-over-year improvement suggests better working capital management or reduced operating losses. Capital expenditures were minimal at $0.5 million, down from $1.2 million, indicating low reinvestment intensity. Free cash flow, calculated as operating cash flow minus capex, was -$23.0 million, reflecting ongoing cash burn. The company did not engage in share repurchases or pay dividends during the period. The improvement in operating cash flow is notable, but the company remains cash flow negative, relying on financing activities or existing cash reserves to fund operations. No major working capital swings or one-time items were explicitly noted in the provided excerpt.